摘要
肾细胞癌(Renal cell carcinoma,RCC)是泌尿系统最常见的肿瘤。由于RCC尚没有可靠的生物标志物,且RCC早期无明显的临床症状,其中约25%的患者在首诊时已发生转移。现代医家对RCC治疗各有宝贵的经验体会;中医治疗RCC是重要方法,可以较显著的改善患者的术后肾功能,降低生物抑制剂和靶向治疗的毒副作用、延长生命周期。作者就中医治疗RCC临床研究进展进行综述。
Renal cell carcinoma(RCC)is one of the most common tumors of the urinary system.Since there are no reliable biomarkers of RCC,and there are no obvious clinical symptoms in the early stage of RCC,about 25%of the patients have metastasis at the first diagnosis.Modern physicians have their own valuable experience in the treatment for RCC.The Chinese medicine is an important method of treating RCC,which can significantly improve the kidney function of patients after operation,reduce toxic and side effect of biological inhibitors and targeted therapy as well as prolong the life cycle.The author reviewed the clinical research progress of traditional Chinese medicine for RCC.
作者
陈晓婷
应栩华
吴雪君
CHEN Xiaoting;YING Xuhua;WU Xuejun
出处
《新中医》
CAS
2019年第4期33-36,共4页
New Chinese Medicine
基金
浙江省医药卫生科技计划项目(2016KYB052)
关键词
肾癌(RCC)
临床研究
综述
Renal cell carcinoma(RCC)
Clinical research
Review
